Market Update (NYSE:LLY): Lilly Announces 2016 Financial Guidance, Updates 2015 Expectations

[PR Newswire] – INDIANAPOLIS, Jan. 5, 2016 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced its 2016 financial guidance and highlighted key events for the upcoming year. The company also reaffirmed its … Read more on this. Eli Lilly and Company (LLY) , with a current market cap of $89.64B, finished yesterday at $82.87. Shares have traded today between $82.89 and $84.74 per share and has traded between $68.31 and $92.85 over the past 12 months. Lilly (LLY) shares are currently priced at 24.09x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s -3.61x earnings multiple for the same period. And for dividend hunters, the company pays shareholders $2.04 per share annually in dividends, yielding 2.42%. In a review of the consensus earnings estimate this quarter, 18 sell-side analysts are looking at $0.78 per share, which would be $0.03 better than the year-ago quarter and a $0.00 sequential decrease. Furthermore, our analysis shows the full-year EPS estimate to be $3.44, which would be a $0.66 improvement when compared to the last year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $5.32 Billion. If realized, that would be a 3.91% increase over the year-ago quarter. More recently, BMO Capital Markets upgraded LLY from Market Perform to Outperform (Nov 13, 2015). Previously, Credit Suisse upgraded LLY from Neutral to Outperform. The average price target for LLY shares by the analysts covering it is $99.85, which is 20.49% above where the stock opened. See more in (NYSE:LLY) Similar Articles: Market Update: Eli Lilly & Company (NYSE:LLY) – Lilly Sets Dates and Conference Calls for 2016 Financial Guidance and Fourth-Quarter 2015 Financial Results Market Update: Eli Lilly & Company (NYSE:LLY) – EXCLUSIVE-US insurers hold back Lilly’s death-defying diabetes drug Market Update: Eli Lilly & Company (NYSE:LLY) – Lilly’s Humalog® 200 units/mL KwikPen® Now Available in U.S. Pharmacies